Clinical Trials
5 trialsNCT00167180 2019-07-30
Post Transplant Donor Lymphocyte Infusion
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT02519712 2018-04-06
Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors
Memorial Sloan Kettering Cancer Center
Phase NA Terminated
NCT02084563 2016-11-08
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
Hospital Israelita Albert Einstein
Phase 2 Completed
NCT00943553 2015-04-13
A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Eisai Inc.
Phase 2 Withdrawn
NCT01247493 2010-11-24
m-FLAI
Seoul National University Hospital
Phase 2 Completed